Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (+-)-aspartic Acid
2. (r,s)-aspartic Acid
3. Ammonium Aspartate
4. Aspartate
5. Aspartate Magnesium Hydrochloride
6. Aspartate, Ammonium
7. Aspartate, Calcium
8. Aspartate, Dipotassium
9. Aspartate, Disodium
10. Aspartate, Magnesium
11. Aspartate, Monopotassium
12. Aspartate, Monosodium
13. Aspartate, Potassium
14. Aspartate, Sodium
15. Aspartic Acid
16. Aspartic Acid, Ammonium Salt
17. Aspartic Acid, Calcium Salt
18. Aspartic Acid, Dipotassium Salt
19. Aspartic Acid, Disodium Salt
20. Aspartic Acid, Hydrobromide
21. Aspartic Acid, Hydrochloride
22. Aspartic Acid, Magnesium (1:1) Salt, Hydrochloride, Trihydrate
23. Aspartic Acid, Magnesium (2:1) Salt
24. Aspartic Acid, Magnesium-potassium (2:1:2) Salt
25. Aspartic Acid, Monopotassium Salt
26. Aspartic Acid, Monosodium Salt
27. Aspartic Acid, Potassium Salt
28. Aspartic Acid, Sodium Salt
29. Calcium Aspartate
30. Dipotassium Aspartate
31. Disodium Aspartate
32. L Aspartate
33. L Aspartic Acid
34. L-aspartate
35. L-aspartic Acid
36. Magnesiocard
37. Magnesium Aspartate
38. Mg-5-longoral
39. Monopotassium Aspartate
40. Monosodium Aspartate
41. Potassium Aspartate
42. Sodium Aspartate
1. 2068-80-6
2. Magnesium L-aspartate
3. Magnesium Aspartate
4. H-asp-oh.mg
5. Monomagnesium Di-l-aspartate
6. L-aspartic Acid, Magnesium Salt (2:1)
7. L-aspartic Acid Magnesium Salt
8. Magnesium (s)-2-amino-3-carboxypropanoate
9. Magnesium L-aspartate Salt
10. 18962-61-3
11. Magnesium L-aspartate (jan)
12. Magnesium;(3s)-3-amino-4-hydroxy-4-oxobutanoate
13. 215533-00-9
14. Dtxsid40889452
15. Mfcd28134197
16. Akos022185485
17. D02026
18. A879494
19. J-012232
20. Q6731379
Molecular Weight | 288.49 g/mol |
---|---|
Molecular Formula | C8H12MgN2O8 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 4 |
Exact Mass | 288.0444070 g/mol |
Monoisotopic Mass | 288.0444070 g/mol |
Topological Polar Surface Area | 207 Ų |
Heavy Atom Count | 19 |
Formal Charge | 0 |
Complexity | 127 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
A - Alimentary tract and metabolism
A12 - Mineral supplements
A12C - Other mineral supplements
A12CC - Magnesium
A12CC05 - Magnesium aspartate
ABOUT THIS PAGE
A magnesium;(3S)-3-amino-4-hydroxy-4-oxobutanoate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of magnesium;(3S)-3-amino-4-hydroxy-4-oxobutanoate, including repackagers and relabelers. The FDA regulates magnesium;(3S)-3-amino-4-hydroxy-4-oxobutanoate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. magnesium;(3S)-3-amino-4-hydroxy-4-oxobutanoate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A magnesium;(3S)-3-amino-4-hydroxy-4-oxobutanoate supplier is an individual or a company that provides magnesium;(3S)-3-amino-4-hydroxy-4-oxobutanoate active pharmaceutical ingredient (API) or magnesium;(3S)-3-amino-4-hydroxy-4-oxobutanoate finished formulations upon request. The magnesium;(3S)-3-amino-4-hydroxy-4-oxobutanoate suppliers may include magnesium;(3S)-3-amino-4-hydroxy-4-oxobutanoate API manufacturers, exporters, distributors and traders.
magnesium;(3S)-3-amino-4-hydroxy-4-oxobutanoate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of magnesium;(3S)-3-amino-4-hydroxy-4-oxobutanoate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right magnesium;(3S)-3-amino-4-hydroxy-4-oxobutanoate GMP manufacturer or magnesium;(3S)-3-amino-4-hydroxy-4-oxobutanoate GMP API supplier for your needs.
A magnesium;(3S)-3-amino-4-hydroxy-4-oxobutanoate CoA (Certificate of Analysis) is a formal document that attests to magnesium;(3S)-3-amino-4-hydroxy-4-oxobutanoate's compliance with magnesium;(3S)-3-amino-4-hydroxy-4-oxobutanoate specifications and serves as a tool for batch-level quality control.
magnesium;(3S)-3-amino-4-hydroxy-4-oxobutanoate CoA mostly includes findings from lab analyses of a specific batch. For each magnesium;(3S)-3-amino-4-hydroxy-4-oxobutanoate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
magnesium;(3S)-3-amino-4-hydroxy-4-oxobutanoate may be tested according to a variety of international standards, such as European Pharmacopoeia (magnesium;(3S)-3-amino-4-hydroxy-4-oxobutanoate EP), magnesium;(3S)-3-amino-4-hydroxy-4-oxobutanoate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (magnesium;(3S)-3-amino-4-hydroxy-4-oxobutanoate USP).
LOOKING FOR A SUPPLIER?